• U 46619: From TP Signaling to Translational Strategy

  2026-08-27

  U 46619, also known as 11,9 epoxymethano-prostaglandin H2, is a selective TP receptor agonist that connects platelet activation with vascular and renal research. This thought-leadership guide shows how to use its mechanism, concentration-dependent readouts, and translational limitations to design stronger platelet, vascular tone, and hypertension studies.

• Self-Amplifying RNA Influenza Vaccines: Key Findings

  2026-08-27

  A 2026 study found that self-amplifying RNA produced stronger and more durable protection against influenza B than conventional nucleoside-modified mRNA in mice, while preserving dose-sparing performance against influenza A. The work highlights influenza-subtype and platform-specific determinants of RNA vaccine immunogenicity and provides a useful framework for comparing RNA vaccine architectures.

• AmpliFold Capture-and-Release for LFA Sensitivity

  2026-08-26

  The AmpliFold strategy addresses a central limitation of lateral flow assays: insufficient time for efficient analyte capture at a narrow test line. In a HER2 model, triggered release from a broad capture region followed by high-affinity rebinding produced up to 16-fold sensitivity enhancement and improved detection of large nanoparticles in buffer and serum.

• DeferoxamineB as a Control for Cell-Death Assays

  2026-08-26

  DeferoxamineB is a powerful iron-dependent perturbation tool for cancer research. This guide explains how to use Deferoxamine to distinguish ferroptosis, apoptosis, autophagy, and cuproptosis while improving metabolic assay design and interpretation.

• Alternariol AOH: From Exposure to Assay Design

  2026-08-25

  Alternariol (AOH) is more than a foodborne mycotoxin model: it is a layered perturbation tool for connecting metabolism, cell death, cytoskeletal remodeling, and hepatic stellate-cell activation. This guide translates recent LX-2 findings into practical assay decisions, controls, and interpretation strategies.

• Stattic Workflows for STAT3-Driven Cancer Research

  2026-08-25

  Stattic is a practical STAT3 inhibitor for connecting pathway mechanism with measurable cancer phenotypes, from nuclear translocation and apoptosis to radiosensitization. This workflow-focused guide shows how to apply it in HNSCC models and cautiously test the NF-κB–IL6–STAT3 biology highlighted in prostate cancer microbiome research.

• Potassium Iodide: Thyroid & Assay Workflows

  2026-08-24

  Potassium Iodide provides a defined iodide source for thyroid uptake, hormone-synthesis, and radioactive iodine competition studies. This protocol-driven guide also explains how to use KI as a carefully controlled compatibility variable alongside responsive liposome research—without confusing an analytical reagent with an immunotherapy payload.

• Stattic Workflows for STAT3 Pathway Research

  2026-08-24

  Stattic provides a practical way to test whether STAT3 signaling drives proliferation, apoptosis, migration, or radiation response in cancer and endothelial models. This workflow-focused guide combines HNSCC benchmarks with a recent lymphangiogenesis study to improve assay design, controls, and troubleshooting.

• Poly-PR, NEAT1, and HSP70 in TDP-43 Condensation

  2026-08-23

  The reference study identifies a NEAT1-dependent mechanism by which C9ORF72-associated poly-PR drives TDP-43 nuclear condensate formation and progressively reduces condensate fluidity. Its findings position HSP70 activity as a dynamic regulator of TDP-43 phase behavior, linking transient stress adaptation to oligomerization, mislocalization, and poly-PR toxicity.

• ECM–Mitochondria Crosstalk in Cell Stress

  2026-08-22

  The 2024 Cell study by Zhang and colleagues identifies extracellular-matrix remodeling as an upstream regulator of mitochondrial homeostasis. Its central model links hyaluronan degradation through TMEM2 to TGF-β signaling, mitochondrial fission, mitochondrial stress responses, and enhanced pathogen defense, providing a framework for testing how extracellular damage is converted into intracellular adaptation.

• Phosphatase Inhibitor Cocktail 3 for Phosphoproteins

  2026-08-22

  Preserve phosphorylation during neuronal OGD, tissue extraction, Western blotting, co-immunoprecipitation, and kinase workflows with a concentrated inhibitor blend. This guide connects practical sample handling to ferroptosis-focused research while separating product-supported parameters from assay-specific optimization.

• Stattic: Practical STAT3 Inhibitor Workflows

  2026-08-21

  Stattic provides a rapid pharmacological route to test STAT3-dependent proliferation, apoptosis, HIF-1 regulation, and radiosensitivity. This guide connects validated HNSCC applications with a carefully bounded extension into keratinocyte and psoriasis research, emphasizing controls, assay compatibility, and troubleshooting.

• One-step TUNEL Cy5 Apoptosis Detection Kit

  2026-08-20

  The One-step TUNEL Cy5 Apoptosis Detection Kit provides a practical DNA-fragmentation endpoint for studying how immunometabolic signaling influences cell fate. This guide connects the IRG1–itaconic acid–TBK1 mechanism with rigorous apoptosis assay design while clarifying what TUNEL can—and cannot—prove.

• Cefodizime: In Vitro Workflow & Troubleshooting

  2026-08-20

  Build more informative antimicrobial assays with Cefodizime, a third-generation cephalosporin antibiotic suited to comparative Gram-positive and Gram-negative testing. This guide connects MIC screening, time-kill experiments, respiratory and urinary pathogen models, and host-response controls while separating product evidence from practical workflow recommendations.

• Gemcitabine HCl in MRI-Guided Tumor Studies

  2026-08-19

  Gemcitabine HCl links mechanism-driven DNA replication inhibition with longitudinal tumor measurement in pancreatic cancer models. Pairing cell-based cytotoxicity testing with multianimal MRI creates a practical way to distinguish molecular activity from whole-tumor treatment response.

8107 records 1/541 page Next 12345 下5页 Last page